Eugene R. Schiff - Publications

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

Journal: JHEP reports : innovation in hepatology

Published: August 17, 2023

Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.

Journal: Journal of hepatology

Published: November 04, 2021

Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.

Journal: Journal of hepatology

Published: November 04, 2021

Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.

Journal: Digestive diseases and sciences

Published: January 11, 2021

Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: August 19, 2020

Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.

Journal: Hepatology (Baltimore, Md.)

Published: August 10, 2020

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 15, 2019

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: June 22, 2018

Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population.

Journal: Journal of translational medicine

Published: May 23, 2018

Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 05, 2018

Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection.

Journal: Hepatology (Baltimore, Md.)

Published: February 07, 2018

Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1.

Journal: The lancet. Gastroenterology & hepatology

Published: January 31, 2018